Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0000919574-25-002448·Aura Biosciences, Inc.
Schedule 13G ownership disclosure
Aura Biosciences Inc
Common Stock, par value $0.00001 per share · CUSIP: 05153U107
Event date: 2025-04-04
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- SUVRETTA CAPITAL MANAGEMENT, LLC
Shares: 3,057,319.00 · Class: 6.1%
- Averill Master Fund, Ltd.
Shares: 2,695,810.00 · Class: 5.4%
- Aaron Cowen
Shares: 3,057,319.00 · Class: 6.1%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000919574-25-002448
- Form type
- SCHEDULE 13G
- Filer
- Aura Biosciences, Inc.
- CIK
- CIK 1501796
- Filed
- Apr 11, 2025
- Reporting period
- Apr 04, 2025
- Description
- Schedule 13G beneficial ownership